[1]CrystalGrowthandDesign,2012,vol.12,p.4567-4573
[1]CurrentPatentAssignee:EISAICOLTD-US2015/51395,2015,A1Locationinpatent:Paragraph0175-0177
[2]CurrentPatentAssignee:OXFORDDRUGDESIGN-WO2021/123237,2021,A1
1509701-26-1
7059-70-3 | 1,3,5-Tri(1-naphthyl)benzene | AA00FGUL | MFCD28975119
681034-80-0 | Ethyl 4-fluoro-5-methyl-1H-pyrazole-3-carboxylate | AA00FH1R | MFCD16619994
6635-66-1 | 2-(Dimethylamino)-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid | AA00FHF2 | MFCD26401819
72754-01-9 | 1,6-Naphthyridin-4(1H)-one | AA00FHRW | MFCD02684596
6634-87-3 | N-(4-Ethoxyphenyl)benzo[d]thiazol-2-amine | AA00FJSV | MFCD02944081
669066-98-2 | 1-(2,2,2-Trifluoroacetamido)cyclopropanecarboxylic acid | AA00FMKA | MFCD20484295
682757-53-5 | 4-Amino-2,3-dihydro-2-methyl-1h-isoindol-1-one | AA00FRS9 | MFCD19252207
70281-35-5 | mannopentaose | AA00FU74 | MFCD28064301
66016-27-1 | 3-tert-Butylcyclobutanecarboxylic acid | AA00FX5C | MFCD01734238
660423-00-7 | 4-(tert-butoxy)-3,3-diMethyl-4-oxobutanoic acid | AA00G1B9 | MFCD24496460